From what I have been reading, in most cases, recurrence-free survival (RFS) is defined as the time from date of randomisation to the date of recurrence of disease (e.g. tumour growth), or death due to any cause.
What about the percentage of participants with RFS?
I have seen clinical trials with primary outcome measures like: 'Percentage of Participants With Recurrence-Free Survival (RFS) At X Months Among All Participants'; let's say that from the result they got a percentage of 80% for Group A and 50% for Group B, what does this '80%' and '50%' exactly mean?
Here is my guess: the higher the percentage of RFS among participants in [a certain time frame], the higher number of participants have not experienced any disease progression / death. Therefore higher % of RFS, the more effective the treatment is. (As for my previous example, Group A would be more effective than Group B).
p.s. I'm a high school student, apologies if I have missed certain information or have misused some medical terms. I would appreciate it if someone can clarify this for me. Thanks :)